Physician profile
Matthew D Hess
NPI 1770568545
$8,323.43
in general payments reported to CMS, 2019-2025
47 companies · $1,600 in 2025
The $1,600 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,703 · 2020: $235 · 2021: $253 · 2022: $951 · 2023: $1,091 · 2024: $1,491 · 2025: $1,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,162 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,161.50 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,001.40 | 2019-2025 | |
| Novo Nordisk INC | $864.87 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $854.89 | 2021-2025 | |
| Lilly USA, LLC | $626.29 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $406.15 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.11 | 2019-2025 | Jardiance, Stiolto Respimat |
| Sanofi-Aventis U.S. LLC | $291.06 | 2019-2024 | |
| Glaxosmithkline, LLC. | $248.18 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $243.71 | 2019-2025 | Repatha, Evenity, Otezla |
| Otsuka America Pharmaceutical, INC. | $215.98 | 2019-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $206.43 | 2022-2025 | Caplyta |
| Merck Sharp & Dohme LLC | $197.86 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Astellas Pharma US INC | $191.70 | 2019-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $165.07 | 2022-2025 | |
| Supernus Pharmaceuticals, INC. | $164.72 | 2019-2022 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $163.16 | 2019-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $161.43 | 2019-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $159.94 | 2019-2025 | Trintellix |
| Novartis Pharmaceuticals Corporation | $147.81 | 2019-2020 | |
| Allergan, INC. | $143.35 | 2019 | |
| Sumitomo Pharma America, INC. | $125.03 | 2023-2025 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $122.96 | 2021-2025 | Gvoke Hypopen |
| Lundbeck LLC | $121.92 | 2022-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $96.16 | 2019-2025 | Austedo Xr, Austedo Xr |
| Axsome Therapeutics, INC. | $89.47 | 2023-2025 | Auvelity |
| Ironwood Pharmaceuticals, INC | $80.92 | 2019-2024 | Linzess |
| Janssen Pharmaceuticals, INC | $77.79 | 2019-2024 | Spravato |
| Corium, LLC | $77.59 | 2023-2025 | Azstarys |
| Radius Health, INC. | $70.06 | 2019 | |
| Insulet Corporation | $65.18 | 2019-2021 | |
| Smith+Nephew, INC. | $60.64 | 2025 | Collagenase Santyl |
| Eisai INC. | $60.20 | 2019-2021 | |
| Amarin Pharma, INC. | $56.42 | 2019-2022 | |
| Exact Sciences Corporation | $53.68 | 2024-2025 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $50.30 | 2022 | |
| Medtronic, INC. | $42.32 | 2024 | Inpen Smart Insulin Delivery System |
| Scilex Pharmaceuticals INC. | $40.65 | 2019 | |
| Neurocrine Biosciences, INC. | $39.23 | 2024 | Ingrezza |
| Dexcom, INC. | $35.21 | 2020-2025 | Dexcom G6 Transmitter |
| Arbor Pharmaceuticals, INC. | $33.49 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $25.08 | 2019-2025 | Zoryve |
| Ultragenyx Pharmaceutical INC. | $23.38 | 2023 | |
| Shire North American Group INC | $22.61 | 2019 | |
| Phathom Pharmaceuticals, INC. | $17.33 | 2024 | Voquezna |
| Corcept Therapeutics | $15.58 | 2019 | |
| Genentech USA, INC. | $13.65 | 2020 | |
| Mylan Specialty L.P. | $13.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.